| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 17, 2026 | Governor Stein Announces $41 Million of Investment and 189 New Jobs for Rural North Carolina | Governor Josh Stein today announced that North Carolina’s Rural Infrastructure Authority (RIA) has approved seven grant requests for local governments totaling $1,657,500. The grants include commitments to create a total of 215 jobs, 26 of ... |
| Apr 16, 2026 | Governor Stein Announces $41 Million of Investment and 189 New Jobs for Rural North Carolina | NORTH CAROLINA, April 16 - Governor Josh Stein today announced that North Carolina’s Rural Infrastructure Authority (RIA) has approved seven grant requests for local governments totaling $1,657,500. The grants include commitments to create ... |
| Jun 23, 2025 | Guest article: The quiet trends reshaping ag: a field guide for builders, backers, and business leaders | Mark S. Brooks is a venture strategist and corporate innovation leader with deep experience across agtech, biotech, climate, and entrepreneurship. A former academic climate scientist-turned-investor, Mark has deployed over $75 million in ve... |
| May 23, 2024 | Accelerate NC Career Celebration spotlights workforce training successes | The “Accelerate NC Career Celebration” at the North Carolina Biotechnology Center on May 7, 2024, brought together key players in the complex ecosystem that makes North Carolina a global leader in life sciences manufacturing. Photo by SP Mu... |
| Apr 11, 2024 | FUJIFILM Diosynth Invests $1.2B in Holly Springs, North Carolina, Manufacturing Facility, Creating 680 New Jobs | The Economic Development Partnership of North Carolina (EDPNC) is a private nonprofit corporation that serves as North Carolina’s statewide economic development organization. Logo courtesy of EDPNC.
Initial investments from FUJIFILM Diosynt... |
| Apr 11, 2024 | FUJIFILM Diosynth Biotechnologies to double Holly Springs biomanufacturing campus | FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs.
When comple... |
| Mar 20, 2024 | Biotalys collaborates with Novonesis on new biofungicide | Biotalys, a Belgian agricultural technology company with a small U.S. subsidiary in Raleigh, has formed a collaboration with Novonesis (formerly Novozymes) to commercialize a biofungicide for fruit and vegetable crops worldwide.
The partner... |
| Mar 12, 2024 | Durham’s Fortrea to divest two businesses for $345M | Fortrea, a global contract research organization (CRO) that was spun off of Burlington-based Labcorp in 2023, will divest two of its businesses to focus more on supporting clinical drug development in phases 1 through 4.
Fortrea, headquarte... |
| Feb 29, 2024 | NCBiotech awards $1.5 million in grants, loans in latest quarter | The North Carolina Biotechnology Center awarded 19 grants and loans totaling more than $1.5 million to universities, bioscience companies and non-profit organizations in the second quarter of its fiscal year.
The awards, made in October, No... |
| Feb 21, 2024 | Atlantic Fish Co. Pioneers Cell Lines for Cultivated Halibut and Other Overfished Wild Species | Biotech startup Atlantic Fish Co., headquartered in Raleigh, North Carolina, leverages cellular agriculture to create seafood free of plastics, mercury, antibiotics, and animal suffering.
Doug Grant and Trevor Ham founded the company in 202... |
| Feb 20, 2024 | Resilience to expand capabilities at RTP facility | National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, announced the expansion of the company’s clinical and commercial drug product manufacturing capabilit... |
| Feb 15, 2024 | Molecular farming key to RTP startup's new sweetener | Elo Life Systems is a step closer to making the world a little sweeter.
The Research Triangle Park spinout from Precision BioSciences has raised an additional $20.5 million in capital, giving it a total of $45 million in funds raised to dat... |
| Feb 1, 2024 | NC ag tech pioneer launching eco-friendly 'plant vaccine' into Brazil soybean market | A North Carolina ag tech company is landing some major success in using a new kind of eco-friendly, portable weaponry in the global war on pests.
Plant Health Care (PHC), a publicly traded company headquartered in Holly Springs, has receive... |
| Jan 5, 2024 | Liquidia secures $100 million in new financing | Morrisville-based Liquidia Corp., which is pursuing final regulatory approval for Yutrepia, its treatment for pulmonary arterial hypertension, has secured two agreements that will give the company an additional $100 million in capital.
Liqu... |
| Sep 16, 2022 | Another Intellia CRISPR therapy flashes potential for one-time, in vivo treatment | An experimental CRISPR-based treatment from Intellia Therapeutics now has encouraging early clinical data showing it led to reductions in levels of a liver protein that drives a rare and potentially fatal swelling disorder. The results repo... |
| Jun 8, 2022 | Astellas joins Pfizer in emerging North Carolina hub, unveiling new $100M gene therapy manufacturing site | The small city of Sanford, NC, was once known for its brick production, but now is quickly becoming a hub in the biotech world. And now Astellas is the latest to pitch its tent in the area.
The company’s gene therapy branch, whi... |
| Nov 24, 2021 | Vestaron: Mexico approves biopesticide to protect crops | RESEARCH TRIANGLE PARK – Some of Mexico’s signature crops could soon be protected from pests with a product developed by a North Carolina company. Regulatory authorities south of the border have approved Vestaron’s SPEAR-Lep, a biopesticide... |
| Nov 5, 2020 | Better Living Through … Biology? | The soil microbiome, key to developing stronger, more resilient crops, is drawing investment ... [+] interest. SOPA Images/LightRocket via Getty Images |
| Sep 29, 2020 | Black Diamond brings in ex-GSK CEO Bob Ingram to chart new path in precision oncology | Black Diamond Therapeutics started the year with a more than $200 million vault onto Nasdaq and a clinic-bound allosteric therapy — and now, the young biotech has GlaxoSmithKline vet Bob Ingram to help pave its way.
Ingram... |
| Nov 16, 2017 | Locus Biosciences Raises $19 Million For New Drug Targeted At Deadly Pathogens | Locus Biosciences, a biotechnology company focused on the development of antimicrobials, has raised $19 million in Series A funding.
A majority of the funding was contributed by ARTIS Ventures, a financial institution that supporting techno... |
| Nov 16, 2017 | Locus Biosciences Raises $19 Million For New Drug Targeted At Deadly Pathogens | Locus Biosciences, a biotechnology company focused on the development of antimicrobials, has raised $19 million in Series A funding.
A majority of the funding was contributed by ARTIS Ventures, a financial institution that supporting techno... |
| Jun 29, 2016 | Morning Read: Pfizer marks milestone with construction of China biotech hub | Gilead Sciences received a greenlight from the U.S. Food and Drug Administration for its combination drug treatment Epclusa for adult patients with chronic hepatitis C virus regardless of whether they have cirrhosis. It is the first drug to... |
| Jul 28, 2015 | Daily funding roundup - July 28, 2015 | Deliveroo took $70M; Kareo pulled in $55M; MacroFab closed $2M
Deliveroo, a food delivery startup based in the United Kingdom, took a $70 million round, according to a report from VentureBeat. The round was led by Greenoaks Capital and Inde... |
| Jun 4, 2015 | Idaho Announces First Statewide AgTech Summit as Global Interest in AgTech Events Continues to Grow | Idaho is the latest state to announce a new agtech event, among a slew of local, national and international events cropping up across the globe.
On June 16, 2015, Idaho will host its first-ever AgriTech summit featuring local agricultural a... |
| Mar 10, 2015 | More on the Apple Watch and ResearchKit, a withdrawn IPO and Ellen Pao takes the stand (Morning Read) | Drug spending was up 13 percent last year – thanks in large part to Hepatitis C drugs Harvoni and Sovaldi.
Some cold water recent IPO announcements: AltheaDx withdrew its $60 million IPO.
Read the details of Ellen Pao’s testimony in the Kle... |
| Feb 13, 2015 | UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy | Spyryx has more than $100,000, largely from angel investors, though it also has taken out a loan from the North Carolina Biotechnology Center. Spyryx is aiming to raise a Series A round and also study the drug’s efficacy in COPD, though it’... |
| Aug 19, 2014 | North Carolina Roundup: BioCryst, Biotech Center, Validic, & More | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Here are this week’s headlines in North Carolina tech and biotech news:
—BioCryst Pharmaceuticals (NASDAQ: BCRX) is moving toward Phase 1 clinical trials of its experimental t... |
| Sep 10, 2013 | A rapid cooling device to help paramedics treat cardiac arrest patients finds Series A funding | There are multiple methods under development and in use for inducing hypothermia, including use of cooling pads and vests, injection of refrigerated saline through a catheter, and intranasal delivery of cooling liquid.
Novocor’s device cool... |
| Feb 17, 2012 | ACOR’s Neuronex acquisition worth up to $133M; hinges on epilepsy drug | Hawthorne, New York-based Acorda said in regulatory filings that Neuronex’s nasal diazepam, referred to as DZNS, fits into the company’s neurology drug portfolio. Acorda’s top-selling drug is multiple sclerosis treatment Amphyra, which gene... |
| Jan 12, 2012 | Vaccine biotech Heat Biologics lands $250K; plans trials for bladder, ovarian cancers | Heat is in phase 2 clinical trials studying its vaccine candidate HS-110 to treat nonsmall cell lung cancer. The company plans to start additional clinical studies in bladder and ovarian cancer this year. Heat’s proprietary Immune Pan-Antig... |
| Dec 29, 2011 | NovaTarg preps for 2012 IND filing for hepatitis C drug candidate | “NovaTarg is making great strides toward the identification of our first drug candidate for the treatment of hepatitis C and other liver-associated diseases,” company founder and CEO Kenneth Batchelor said in a statement. “We look forward t... |
| Dec 8, 2011 | 4 tips for life sciences companies seeking foundation funding | “Our job is to put the ball in the air, throw the long ball,” he said.
Angel investors and venture capitalists are not the only path for companies looking to traverse the so-called valley of death. Life sciences companies have a funding alt... |
| Nov 18, 2011 | Personalized medicine’s opportunities and challenges for clinicians, business | Not all personalized medicine drugs and diagnostics will have such a speedy path through the FDA. But the companies, academics and investors who have a stake in personalized medicine are working to smooth the path for future personalized me... |
| Oct 21, 2011 | CNS therapies firm Aerial BioPharma launches $12M fundraising round | Khayrallah’s former company, Durham, North Carolina-based Addrenex was founded in 2006 supported by angel investment and loans from the North Carolina Biotechnology Center. The company’s lead drug candidate was Clonicel, a compound being de... |
| Sep 8, 2011 | ECU toxicologist gets $143K Biotech Center grant to study nanoparticle risks | Brown, an assistant professor in ECU’s Department of Pharmacology and Toxicology at the Brody School of Medicine, focuses his nanotechnology research on carbon nanotubes and the emerging study of nanomaterials’ effects on the human body. Ca... |
| Aug 2, 2011 | N.C. Biotech Center awards $2.5M grant to launch marine biotechnology center | The four-year grant will go toward establishing the Marine Biotechnology Center of Innovation, or MBCOI, which will be charged with working with researchers and businesses to develop new products in areas such as healthcare and diagnostics,... |
| Jun 15, 2011 | Arbovax preparing for dengue fever vaccine clinical trials | Arbovax’s technology modifies a virus such that it is able to grow normally in insect cells but is limited in its ability to grow in the cells of a mammal. The mutation of the virus means that a mammal infected by the virus would not see th... |
| Jun 8, 2011 | Neoprobe snags another Alseres exec | Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Neoprobe snags another... |
| Jun 3, 2011 | N.C. Biotech Center names biotech veteran to head western regional office | The Biotechnology Center is a private, nonprofit corporation supported by the North Carolina General Assembly. The Biotechnology Center, headquartered in Research Triangle Park, has five regional offices that carry out the center’s mission ... |
| Apr 29, 2011 | Biosciences brought N.C. more than $1.1B in the last year, report says | The report covering the 12 months ending April 25 includes equity investments, licensing payments, grants and investments for buildings and equipment. NCBIO compiles the report by tracking news stories of funding and investments. The $1.1 b... |
| Mar 16, 2011 | Diagnostics company AAD raises $11 million B round | Diagnostic device company Advanced Animal Diagnostics has secured $11 million in a series B round, which the company will pour into continued research and development of a detection tool for mastitis in dairy cows.
The round was led by Inte... |
| Mar 15, 2011 | NC diagnostics device company AAD raises $11M in series B round | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| Feb 8, 2011 | North Carolinian companies look hard for government incentives | “Innovation” was an oft-mentioned buzzword at the annual Emerging Issues Forum, an event sponsored by North Carolina State University that this year focuses on healthcare.
Underlying the discussion about health practices and new drugs is th... |
| Feb 7, 2011 | North Carolina biotechs seek incentives but state has no money to give | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| A rapid cooling device to help paramedics treat cardiac arrest patients finds Series A funding | A portable device for ambulances could someday soon make it easier and quicker for emergency responders to treat cardiac arrest and stroke victims with therapeutic hypothermia.
Novocor Medical Systems Inc. is developing HypoCore, a device t... |
| CNS therapies firm Aerial BioPharma launches $12M fundraising round | The team that built Addrenex Pharmaceuticals from startup into a $29 million exit without raising a dime of venture capital is making another run with a new company – Aerial BioPharma.
Morrisville, North Carolina-based Aerial is focused on ... |
| UNC spinout looking to one-up Kalydeco with one-size-fits-all cystic fibrosis therapy | Cystic fibrosis has become the poster child for precision medicine – most new therapies are carefully tailored to a CF patient’s genetic makeup. University of North Carolina spinout Spyryx Biosciences is proposing a one-size-fits-all approa... |
| 4 tips for life sciences companies seeking foundation funding | Max Wallace, CEO of Accelerate Brain Cancer Cure, uses a football analogy when explaining his foundation’s approach to funding life sciences research.
Large companies aren’t getting into the game, which they see as too risky. But the stakes... |
| N.C. Biotech Center awards $2.5M grant to launch marine biotechnology center | The North Carolina Biotechnology Center has awarded a $2.5 million grant to establish a marine biotechnology center that would support the commercialization of biotechnology-based products coming from research and development originating on... |
| NovaTarg preps for 2012 IND filing for hepatitis C drug candidate | Drug discovery startup NovaTarg is ramping up preclinical research in preparation of an expected investigational new drug application filing for the company’s first drug candidate — a new hepatitis C treatment .
The Research Triangle Park, ... |
| Arbovax preparing for dengue fever vaccine clinical trials | Vaccine developer Arbovax has raised $1.7 million in a Series A round of financing that the company is using to prepare for clinical trials on a dengue fever vaccine candidate.
Raleigh, North Carolina-based Arbovax has a platform vaccine te... |
| ACOR’s Neuronex acquisition worth up to $133M; hinges on epilepsy drug | Central nervous system therapies company Neuronex is being acquired by Acorda Therapeutics (NASDAQ:ACOR) in a deal valued at up to $133 million, yielding to Acorda a novel epilepsy treatment nearly ready for filing with the U.S. Food and Dr... |
| North Carolina biotechs seek incentives but state has no money to give | “Innovation” is one of the most talked about buzz words humming at the annual Emerging Issues Forum, an event sponsored by North Carolina State University that this year focuses on healthcare. The forum run through Tuesday in Raleigh, North... |
| ECU toxicologist gets $143K Biotech Center grant to study nanoparticle risks | Nanoparticle exposure research is getting a boost from a North Carolina Biotechnology Center grant.
The Biotech Center has awarded East Carolina University toxicologist Jared Brown $143,308 to study the hazards from inhaling nanomaterials d... |
| N.C. Biotech Center names biotech veteran to head western regional office | The North Carolina Biotechnology Center has named an executive director to oversee its regional office in western North Carolina.
Jonathon Lawrie is taking the reins of the Biotechnology Center’s western office in Asheville, North Carolina.... |
| Biosciences brought N.C. more than $1.1B in the last year, report says | North Carolina life science companies hauled in more than $1.1 billion worth of investments and grant money in the last year, according to a report from the North Carolina Biosciences Organization.
NCBIO, a Durham, North Carolina-based trad... |
| Morning Read: Pfizer marks milestone with construction of China biotech hub | Pfizer world headquarters in Manhattan on May 5, 2014 (Photo by Spencer Platt/Getty Images)
TOP STORIES
Pfizer is opening a $350 million biotech hub in Hangzhou city, China, marking its first such facility in the country. It will produce bi... |
| Personalized medicine’s opportunities and challenges for clinicians, business | Perhaps the biggest personalized medicine breakthrough of 2011 was the progress of melanoma drug Zelboraf and its companion diagnostic, both of which sped through regulatory approval.
Clinical trials demonstrated that Roche‘s (OTC:RHHBY) Ze... |
| Vaccine biotech Heat Biologics lands $250K; plans trials for bladder, ovarian cancers | Vaccine technology company Heat Biologics has come into more money to help pay for clinical trials for its novel cancer-fighting immunotherapy.
The North Carolina Biotechnology Center awarded the biotechnology company a $250,000 loan to cov... |
| More on the Apple Watch and ResearchKit, a withdrawn IPO and Ellen Pao takes the stand (Morning Read) | The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to it... |
| NC diagnostics device company AAD raises $11M in series B round | Diagnostic device company Advanced Animal Diagnostics has secured $11 million in a series B round of equity financing that the company will pour into continued research and development of a detection tool for mastitis in dairy cows.
The rou... |
